3rd Quarter - Report

HEALTH AND MEDICINE COUNSEL for PROLONG PHARMACEUTICALS LLC

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Access to treatments for people with Sickle Cell Disease, treatment center model Sickle Cell Legislation Engaging NIH/CDC on hematology issues Research at NHLBI & NIDDK Cures Implementation & Patient Centered efforts

LobbyistCovered position, as disclosed
DANE CHRISTIANSEN Legislative Consultant
DALE P DIRKS Legislative Consultant
PHILIP GOGLAS Legislative Consultant
JOSEPH STEWART Legislative Consultant

Contacted: Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

FY17 & FY18 funding for Blood Disorders Programs, TBI & Transplantation

LobbyistCovered position, as disclosed
DANE CHRISTIANSEN Legislative Consultant
DALE P DIRKS Legislative Consultant
PHILIP GOGLAS Legislative Consultant
JOSEPH STEWART Legislative Consultant

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.